Not a Lexis+ subscriber? Try it out for free.
LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
PARIS – (AP) Sanofi-Aventis has settled three patent infringement lawsuits in the U.S. related to generic versions of colon cancer treatment Eloxatin, the French drug maker said Thursday. Under terms of the settlements, the three generic drug makers Teva Pharmaceuticals USA, Inc., Fresenius Kabi and Sandoz will suspend sales of their products. . . . Full version available to lexis.com subscribers.